The most commonly reported ones include nausea, vomiting, indigestion, diarrhea, constipation, abdominal pain, and stomach upset, which go away on their own for many people as their body gets used to the medication
Microdosing tirzepatide produces slower weight loss, which theoretically reduces gallbladder risk by minimizing rapid bile composition changes
Comparing Semaglutide to SGLT2 Inhibitors for Kidney Protection SGLT2 inhibitors (dapagliflozin, empagliflozin) remain the first-line add-on therapy for kidney protection in type 2 diabetes based on the DAPA-CKD (N=4,304) and EMPA-KIDNEY trials [8, 9]
In women being evaluated for ovulatory dysfunction or subfertility, mid-luteal serum progesterone is the key functional test